Tag: SARS-CoV-2 and COVID-19 Research

What the study found Oral nirmatrelvir-ritonavir did not reduce hospitalization or death among vaccinated higher-risk people with SARS-CoV-2 infection. Why the authors say this matters The abstract does not describe additional implications beyond reporting this result. What the researchers tested The researchers reported findings from two open-label trials of nirmatrelvir-ritonavir in vaccinated higher-risk outpatients with…